Qyuns Therapeutics Co., Ltd. (QYUNS-B) disclosed a share buyback in a Next Day Disclosure Return filed on 4 June 2026.

The company repurchased 25,200 H shares on the Hong Kong Stock Exchange on 4 June 2026 at prices ranging from HKD 15.31 to HKD 15.80, with a volume-weighted average price of HKD 15.55. The total consideration was approximately HKD 0.39 million.

Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.0112 % to 224.00 million, while treasury shares increased to 3.07 million. Total issued shares remained unchanged at 227.07 million.

The buyback was executed under the repurchase mandate approved on 29 May 2026, which authorises the company to repurchase up to 22.44 million shares. Cumulative repurchases under this mandate now stand at 363,400 shares, equivalent to 0.162 % of the issued share capital on the mandate date.

In accordance with listing rules, QYUNS-B is subject to a moratorium on new share issues or treasury share disposals until 4 July 2026.